Literature DB >> 21172056

Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae.

Shao Li1, Bo Zhang, Duo Jiang, Yingying Wei, Ningbo Zhang.   

Abstract

BACKGROUND: Traditional Chinese Medicine (TCM) is characterized by the wide use of herbal formulae, which are capable of systematically treating diseases determined by interactions among various herbs. However, the combination rule of TCM herbal formulae remains a mystery due to the lack of appropriate methods.
METHODS: From a network perspective, we established a method called Distance-based Mutual Information Model (DMIM) to identify useful relationships among herbs in numerous herbal formulae. DMIM combines mutual information entropy and "between-herb-distance" to score herb interactions and construct herb network. To evaluate the efficacy of the DMIM-extracted herb network, we conducted in vitro assays to measure the activities of strongly connected herbs and herb pairs. Moreover, using the networked Liu-wei-di-huang (LWDH) formula as an example, we proposed a novel concept of "co-module" across herb-biomolecule-disease multilayer networks to explore the potential combination mechanism of herbal formulae.
RESULTS: DMIM, when used for retrieving herb pairs, achieves a good balance among the herb's frequency, independence, and distance in herbal formulae. A herb network constructed by DMIM from 3865 Collaterals-related herbal formulae can not only nicely recover traditionally-defined herb pairs and formulae, but also generate novel anti-angiogenic herb ingredients (e.g. Vitexicarpin with IC50=3.2 μM, and Timosaponin A-III with IC50=3.4 μM) as well as herb pairs with synergistic or antagonistic effects. Based on gene and phenotype information associated with both LWDH herbs and LWDH-treated diseases, we found that LWDH-treated diseases show high phenotype similarity and identified certain "co-modules" enriched in cancer pathways and neuro-endocrine-immune pathways, which may be responsible for the action of treating different diseases by the same LWDH formula.
CONCLUSIONS: DMIM is a powerful method to identify the combination rule of herbal formulae and lead to new discoveries. We also provide the first evidence that the co-module across multilayer networks may underlie the combination mechanism of herbal formulae and demonstrate the potential of network biology approaches in the studies of TCM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21172056      PMCID: PMC3024874          DOI: 10.1186/1471-2105-11-S11-S6

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


Background

Traditional Chinese Medicine (TCM) is an important part of the current medical system. It aims to restore the whole-body balance in patients by using herbal formula (Fang-Ji in Mandarin), which is usually composed of two or more medicinal herbs and has the capacity of systematically treating disease [1]. Naturally occurring herbs and herbal ingredients organized into certain formula have been shown to have potential interaction effects. These include mutual enhancement, mutual assistance, mutual restraint and mutual antagonism [2,3]. For example, synergistic interactions occur when the efficacy of combinations of herbs (or ingredients) is greater than the summed responses of each individual herb or ingredient. Adams et al. [4] recently reported the synergistic, additive and antagonistic effects exerted by different combinations of six herbal extracts on the viability of prostate cancer cell lines. Wang reported that a Realgar-Indigo naturalis formula is beneficial for the treatment of promyelocytic leukemia; the synergistic effects exerted by several components of this formula are well documented [5]. Ung et al. [6] conducted an analysis of 394 TCM herb pairs and 2470 non-TCM herb pairs using artificial intelligence methods and considering four classes of herbal properties as features including character, taste, meridian, and toxicity level. Their study revealed that herb pairs in TCM contain features distinguishable from those of non-TCM herb pairs. Schmidt et al.[7] believed that mixtures of interacting compounds produced by plants may become a valuable asset and an important resource for drug discovery, especially for the development of combinational therapeutics. However, there is still a lack of appropriate methods to learn how and why many herbs are grouped in certain formulae, and the combination rule embedding numerous herbal formulae remain unknown. Traditionally herbs have taken different roles in a typical herbal formula; they are usually expressed in the organization order as Master, Adviser, Soldier and Guide (MASG), each of which is given certain natural properties including Cold, Cool, Neutral, Warm or Hot. Understanding the combination rule of herbal formulae will not only benefit the modernization of TCM but may also be helpful for the way drugs are studied. A good example of the potential of TCM involves angiogenesis. TCM is known to be effective for the treatment of angiogenesis which is the main type of pathological vascular growth associated with various diseases such as cancer and rheumatoid arthritis [8,9]. We know that more than 60% of the current cancer chemotherapeutic agents are natural products or small molecules based on natural product leads [10,11]. Many pro-angiogenic and anti-angiogenic plant components are potentially useful for curing angiogenic disorders and are well tolerated [9]. Especially, herbs originally used for treating “Collaterals (Luo in Mandarin) diseases” in TCM have been found to be active on angiogenic disorders [12]. As a consequence, combining traditional herbal formulae with existing biological knowledge might allow researchers to rapidly identify combination treatments for angiogenic disorders. Recently, a remarkable development has been the use of systems biology, especially network biology, in drug study. This methodology has revealed the systematic mechanisms of complex disease and has highlighted the paradigm shift from “one drug, one target” to “multicomponent therapeutics, biological networks” [13,14]. Even though the scientific community has high expectations for systems pharmacology, this field is still in its infancy because of a poor understanding of cell behaviours and drug-protein interactions. TCM formula is considered to be an empirical system of multicomponent therapeutics which potentially meets the demands of treating a number of complex diseases in an integrated manner [3,14,15]. So, in order to find a relationship between groups of drugs and complex diseases, it is important to introduce a powerful approach to bridge the tradition and the modern, and pursue a priori knowledge about the combination rules embedded in TCM. In this work, we developed a Distance-based Mutual Information Model (DMIM) to extract the herb relationships from plentiful herbal formulae. This method was then used to construct the “herb network” from 3865 Collaterals-related herbal formulae, following by in vitro experiments designed to evaluate the angiogenic effects and synergistic properties of strongly connected herbs and herb pairs. A new concept of “co-module” was further proposed and network biology analyses were conducted to explore the potential combination mechanism of the networked herbal formulae.

Methods

Data sources of herbal formulae

Candidate herbal formulae selection

TCM values the “Collaterals” theory and therapy. Using “Collaterals (Luo)” as the keyword, we searched the SIRC-TCM Herbal Formula database (http://www.tcm120.com/1w2k/tcm_recipe.asp) which contains 0.14 million herbal formulae. Then we collected 3865 herbal formulae with formula names and functions, or herb’s meridian tropism (Gui-jing in Mandarin), or targeted syndromes and diseases containing the keyword. We standardized the herbal formulae by substituting all the polysemes, synonyms and acronyms of the herbs in the dataset using the standardized Herb Name list. The standardized Herb Name list consists of 737 herbs. The 3865 Collaterals-related herbal formulae, as examples, will be subject to the following DMIM analysis.

Traditionally-defined herb pairs

The herb pair is the basic unit of a herbal formula. To evaluate the reliability and utility of the DMIM-extracted herb network, 600 traditionally-defined herb pairs recorded in [16] and 301 herb pairs from [17] were collected. This resulted in 775 non-redundant traditionally-defined herb pairs made up of 737 separate herbs in the Collaterals-related herbal formulae.

Establishment of DMIM Scoring System

Numerical representation for herbal formulae

In the DMIM, we turn the normalized formula data into a numeral matrix to indicate the relative position of the herbs in a formula. Assuming there are a total of n herbs and m formulae, we assign serial numbers to all the herbs from 1 to n. As illustrated in Table 1, we use a m×n matrix A = (a)* to indicate the formula where the ith row vector denotes the components of the ith formula, and a is the number of the position of the jth herb in ith formula ( a =0 means herb j is absent in formula i). To eliminate the impact of the total number of herbs in one formula, we define the matrix B=(b) as where k denotes the total number of herbs in a formula.
Table 1

Examples for the numerical representation of herbal formulae

Formulaherb1herb2herb3herb4herb5herb6herb7herb8herb9herb10
Formula 100.500.2501000.750

Formula 20.3750.6250.8750.1250.75010.2500.5

Formula 30.5000010000

*Assume there are a total of 10 herbs denoted by herb1, herb2…herb10 (j=1, 2…,10), and three herbal formulae containing the following herbs in sequence (i=1,2,3): Formula 1: herb4, herb2, herb9 and herb6 (k=4); Formula 2: herb4, herb8, herb1, herb10, herb2, herb5, herb3 and herb7 (k=8); and Formula 3: herb1 and herb6 (k=2). For herb2 in Formula 1, we calculated that a =2 and b=2/4=0.5. The matrix representation for this artificial data set is shown in the table.

Examples for the numerical representation of herbal formulae *Assume there are a total of 10 herbs denoted by herb1, herb2…herb10 (j=1, 2…,10), and three herbal formulae containing the following herbs in sequence (i=1,2,3): Formula 1: herb4, herb2, herb9 and herb6 (k=4); Formula 2: herb4, herb8, herb1, herb10, herb2, herb5, herb3 and herb7 (k=8); and Formula 3: herb1 and herb6 (k=2). For herb2 in Formula 1, we calculated that a =2 and b=2/4=0.5. The matrix representation for this artificial data set is shown in the table. From this we had matrix B , where b indicates the relative position of herb j in the formula i. Finally, the real data set is represented by a 3865×737 matrix. Then, for given two herbs, x and y, we deduce that the tendency of x and y to form a herb pair is dependent on two factors: mutual information entropy characteristics and the average distance between herbs.

Mutual information entropy

To begin with, we calculate the traditional mutual information entropy [21] for x and y as: . Here is the frequency that herb x and herb y occurred, and I(x, y,i) is the indicator function of x and y, showing whether herb x and y coexist in the formula i. is the frequency of herb x. It is the same with P(y). A large value of MI(x, y) indicates a strong correlation between herb x and herb y .

Between-herb-distance

Considering a later order indicates a less importance in the organization of Master, Adviser, Soldier or Guide herbs in a herbal formula, we assume that the further the distance between two herbs in a formula, the less likely they are to be relevant to one another. The distance between herb x and herb y in the ith formula, called the “between-herb-distance”, is defined as: d(x, y, i) = |B(x,i) - B(y, i)|. The average distance of herb x and herb y in the dataset is .

DMIM scoring system

The DMIM combines the mutual information (MI) entropy characteristics and the average distance between herbs (d) to form a scoring system, , which describes the tendency of herb x and herb y to form a herb pair. So when two herb pairs share the same information entropy, the one with the smaller average distance shows a stronger connection. When two herb pairs have the same average distance, the one with the larger information entropy shows a greater interaction.

Evaluation of the DMIM-extracted herb network

In vitro assays for evaluating angiogenic activities of DMIM-extracted herbs

We selected major herbal ingredients from DMIM outputs to evaluate angiogenic activities. Two kinds of endothelial cell proliferation assays, namely with or without vascular endothelial growth factor (VEGF) stimulation, were used to evaluate respectively the anti-angiogenic or the pro-angiogenic activity of herbal ingredients. Only the positive results were reported. Human Umbilical Vein Endothelial Cells (HUVECs) from Cascade Biologics (Portland, USA) were cultured in endothelial cell medium (Sciencell Research Laboratory) together with 10% fetal bovine serum and endothelial cell growth supplement. This mixture was sub-cultured using a 1:2 ratio with Trypsin/EDTA solution provided by the manufacturer. Herbal ingredients were purchased from the National Institute for the Control of Pharmaceutical and Biological Products, China. HUVECs (5×103 per well) in a 96-well plate were starved with 0.1% FBS medium and then treated with or without VEGF (5-10 ng/ml) along with different concentrations of herbal ingredients for 48 hours. Cell viability was determined by Cell Counting Kit (CCK-8, Dojindo, Japan) following the measurement of optical density values using MRX Revelation Absorbance Reader.

Herb interaction measurement of DMIM-extracted herb pairs

We investigated whether combination effects were produced by DMIM-extracted herb pairs and whether there was a role for the natural properties of the herbs. The highest single compound model [18] was used as the reference model for measuring additivity to identify herbal interactions such as synergism or antagonism. The combination effects were determined by selecting the greatest effect produced by each of the combination’s individual compounds using similar concentrations as in the combination. Positive or negative deviations from this predicted additivity demonstrated synergistic or antagonistic interactions.

Co-module analysis for the DMIM-extracted herbal formula

Co-module concept, herbal formula selection and biological data preparation

To further explore the combination mechanism of DMIM-extracted herbal formulae, we propose a new concept of “co-module” based on the assumption that there may exist certain consistent and common biological patterns, which act as “co-modules”, underlying networked herbs and their targeted diseases simultaneously. We took a famous formula, “Liu-wei-di-huang” (LWDH, also known as Rehmannia Six, Six Ingredient Rehmannia or Rokumi-gan), as an example, since we found that all six herbs of this formula are connected closely in the DMIM-extracted herb network including Shan-zhu-yu (Fructus Corni), Ze-xie (Rhizoma Alismatis), Dan-pi (Cortex Moutan), Di-huang (Radix Rehmaniae), Fu-ling (Poria Cocos) and Shan-yao (Rhizoma Dioscoreae). Then, we collected the biological entities (genes or gene products) affected by individual herbs (compounds) of LWDH from PubMed and China National Knowledge Infrastructure (http://www.cnki.net). This resulted in a total of 146 manually collected genes or gene products, called LWDH genes, contributed respectively to the actions of the LWDH constituent six herbs. 127 LWDH genes were nodes of the protein-protein interaction (PPI) network (HPRD, release 7). Next, we collected the documented diseases for which the LWDH formula may serve as a potential treatment. This resulted in 16 diseases containing 9 types of cancer (Prostate cancer, Melanoma, Stomach cancer, Breast cancer, Esophageal cancer, Lung cancer, Hepatocellular carcinoma, Multiple myeloma and Leukemia), 5 diseases with dysfunction of the neuro-endocrine-immune-metabolism system (Parkinson disease, Asthma, Allergy, Rheumatoid arthritis and Diabetes), and 2 cardiovascular disorders (Hypertension and Atherosclerosis) (see literature in Additional file 1). By mapping these 16 diseases into the OMIM database, we identified 73 exclusive phenotypes with OMIM IDs and obtained 224 disease genes called LWDH-disease genes, 173 of which were networked in HPRD.

Performing co-module analysis for LWDH and LWDH-treated diseases

We conducted the co-module analysis from the following three aspects. (1) We analyzed the enriched KEGG pathways for either LWDH genes or LWDH-disease genes with a false discovery rate less than 0.05 by Fisher Exact test in DAVID [19]. (2) We evaluated the “closeness”(average shortest path) between LWDH genes and LWDH-disease genes in the PPI network and used the permutation test to calculate the statistical significance of the average shortest path. Here we kept the original 127 LWDH genes and randomly selected other 173 disease genes from 1273 networked genes in all 3074 non-redundant disease genes stored in the OMIM moridmap.txt (Feb 22, 2008); this was repeated independently 2000 times. (3) We calculated the average phenotype similarity score determined by the cosine of vector angle [20] of 73 phenotypes of LWDH-diseases, and evaluated the statistical significance by comparison with randomly selected 73 OMIM phenotypes for 2000 times.

Statistical analysis

The mutual information statistics were transformed to equivalent odds ratios using monotonic transform and then subjected to standard χ2 test. In doing so, we used χ2 test to test whether the occurrence of the two herbs in the formulae is correlated with each other by generating a contingency table. Experimental data from the in vitro assay were presented as mean±SD (Standard Deviation) of four independent experiments with six repeat wells for each experiment. The statistical difference between treatments was determined by the t test.

Results

DMIM-extracted herb network from Collaterals-related formulae

DMIM was used for extracting the combination rule of 3865 Collaterals-related formulae. In all 3865 formulae, we found that eight of the top 10 most frequently occurring herbs (Table 2) are reported to pro-angiogenesis or anti-angiogenesis activity [9,22]. This provides evidence that the Collaterals-related formulae may have a possible relationship with angiogenic disorders. Each of the top 100 DMIM-extracted herb pairs had statistical significance (P < 0.05, x2 test). Table 3 summarized the top 20 DMIM-extracted herb pairs with the highest rankings; six of these herb pairs are novel when compared with traditionally-defined herb pairs [16,17]. Interestingly, we found that Gan-cao (Radix Rhizoma Glycyrrhizae), a commonly-used supplementary herb (“Guide” in MASG), ranked 2nd with a frequency of 38.37% in all 3865 herbal formulae. However, the position of herb pairs containing Gan-cao fell to 195 (Table 3), suggesting that the DMIM method was able to balance the frequency, independence, and relative distance in the herbal formulae. Figure 1 shows that we constructed a herb network by using the interactions of the top 100 herb pairs extracted by DMIM, in which we found that full or part of six classical herbal formulae are nicely recovered. The distinct modular feature is also observed from the DMIM-extracted herb network.
Table 2

Top 10 herbs in 3865 Collaterals-related formulae

RankHerbs in Collaterals-related herbal formulaNatural PropertyFrequencyAngiogenesis activity [9,22]
Chinese NameEnglish Name
1Dang-guiRadix Angelicae SinensisWarm49.50%Pro-angiogenesis
2Gan-caoRadix Rhizoma GlycyrrhizaeNeutral38.37%Anti-angiogenesis
3Chuan-xiongRhizoma ChuanxiongWarm32.32%Pro-angiogenesis
4Chi-shaoRadix Paeoniae RubraCool30.79%Pro-angiogenesis
5Dan-shenRadix et Rhizoma Salviae MiltiorrhizaeCool29.62%Pro-/Anti-angiogenesis
6Niu-xiRadix Achyranthis BidentataeNeutral26.39%Unknown
7Huang-qiRadix AstragaliWarm25.85%Pro-angiogenesis
8Hong-huaFlos CarthamiWarm24.94%Unknown
9Di-huangRadix RehmanniaeCold24.92%Pro-angiogenesis
10Bai-shaoRadix Paeoniae AlbaCool21.89%Pro-angiogenesis
Table 3

Top 20 DMIM-extracted herb pairs

RankHerb 1Herb 2DMIM Score
Chinese NameEnglish NameNatural PropertyChinese NameEnglish NameNatural Property
1Mo-yaoMyrrhNeutralRu-xiangFrankincenseWarm2.9528
2Hong-huaFlos CarthamiWarmTao-renSemen PersicaeNeutral1.8057
3E-zhuRhizoma CurcumaeWarmSan-lenRhizoma SparganiiNeutral0.97254
4Long-guDrgon's Bones, FossilizidNeutralMu-liConcha OstreaeCool0.78572
5Da-zaoFructus JujubaeWarmShen-jiangRhizoma Zingiberis RecensWarm0.63477
6Quan-xieScorpioNeutralWu-gongScolopendraWarm0.56607
7Du-huoRadix Angelicae PubescentisWarmQiang-huoRhizoma et Radix NotopterygiiWarm0.45846
8Cang-zhuRhizoma AtractylodisWarmHuang-baiCortex PhellodendriCold0.43511
9Pu-huangPollen TyphaeNeutralWu-ling-zhiTrogopterus DungWarm0.42285
10Bai-zhuRhizoma Atractylodis MacrocephalaeWarmFu-lingPoriaNeutral0.41082
11Shi-chang-puRhizoma Acori TatarinowiiWarmYuan-zhiRadix PolygalaeWarm0.40238
12Chi-shaoRadix Paeoniae RubraCoolTao-renSemen PersicaeNeutral0.39792
13*Jiang-canBombyx BatryticatusNeutralQuan-xieScorpioNeutral0.3707
14Ban-xiaRhizoma PinelliaeWarmChen-piPericarpium Citri ReticulataeWarm0.34629
15*Dang-shenRadix CodonopsisNeutralHuang-qiRadix AstragaliWarm0.34084
16*Chuan-xiongRhizoma ChuanxiongWarmHong-huaFlos CarthamiWarm0.32943
17*Chuan-xiongRhizoma ChuanxiongWarmTao-renSemen PersicaeNeutral0.31513
18Chuan-xiongRhizoma ChuanxiongWarmDang-guiRadix Angelicae SinensisWarm0.29861
19*Chi-shaoRadix Paeoniae RubraCoolHong-huaFlos CarthamiWarm0.29351
20*Bai-zhuRhizoma Atractylodis MacrocephalaeWarmDang-shenRadix CodonopsisNeutral0.29154
195Bai-shaoRadix Paeoniae AlbaCoolGan-caoRadix Rhizoma GlycyrrhizaeNeutral0.052203

*: Herb pairs extracted by DMIM but not recorded in traditionally-defined herb pairs.

Figure 1

DMIM-extracted herb network from 3865 herbal formula.This herb network is constructed from the top 100 herb pairs extracted by DMIM. Herbs with different natural properties and six classical herbal formulae are presented in the network. Data about only two interacted herbs are not shown.

Top 10 herbs in 3865 Collaterals-related formulae Top 20 DMIM-extracted herb pairs *: Herb pairs extracted by DMIM but not recorded in traditionally-defined herb pairs. DMIM-extracted herb network from 3865 herbal formula.This herb network is constructed from the top 100 herb pairs extracted by DMIM. Herbs with different natural properties and six classical herbal formulae are presented in the network. Data about only two interacted herbs are not shown.

Measurement of angiogenic activities for DMIM-extracted modular herbs

As shown in Figure 1, the hub module or the interconnected sub-network in the DMIM-extracted herb network is centered on the most frequently occurring herbs, Chuan-xiong (Rhizoma Chuanxiong) and Dang-gui (Radix Angelicae Sinensis). We extended this hub module to all herb pairs with statistical significance (χ2 test, P<0.05) (Figure 2A) and assumed that herbs presented in this module could have potential angiogenic activities. By selecting the major herbal ingredients in these herbs and taking their natural properties into consideration, the following in vitro experimental results support our hypothesis. As shown in Figure 2B, in the hub module, Vitexicarpin (VIT) and Timosaponin A-III (TSA) as major ingredients taken from two herbs with Cold properties were very active on inhibiting endothelial cell proliferation (IC50VIT=3.2μM; IC50TSA=3.4μM respectively). Also, Hydroxysafflor yellow A (HYA) and Astragaloside (AST) from herbs with Hot properties had partial pro-angiogenesis activities when compared with the VEGF treatment group. Another trend (Figure 2B) was that Berberine from Huang-bai (Cortex Phellodendri) and Tetramethylpyrazine (TMP) from Chuan-xiong had a biphasic effect on endothelial cells proliferation. Lower doses caused an increase in cell proliferation whereas higher doses resulted in an anti-angiogenic response. Overall, the experimental results validated the potential angiogenic activities of the modular herbs.
Figure 2

Angiogenic activities of major ingredients in DMIM-extracted herbs. A. The extended hub module in DMIM-extracted herb network. Each node corresponds to a herb colored according to their natural properties. The size of each node is proportional to the number of herbs connecting to it. A solid line links a herb pair while the width of the lines is proportional to the DMIM score. B. Experimental results of the herb ingredients in the module. The pro- or anti-angiogenic effects of each herb were delineated by pro- or anti-angiogenic screening model respectively.

Angiogenic activities of major ingredients in DMIM-extracted herbs. A. The extended hub module in DMIM-extracted herb network. Each node corresponds to a herb colored according to their natural properties. The size of each node is proportional to the number of herbs connecting to it. A solid line links a herb pair while the width of the lines is proportional to the DMIM score. B. Experimental results of the herb ingredients in the module. The pro- or anti-angiogenic effects of each herb were delineated by pro- or anti-angiogenic screening model respectively.

Measurement of DMIM-extracted modular herb interactions

We evaluated whether modular herbs with different properties had potential combination effects. Figure 3 shows that HUVECs were treated with different compound combinations in a 6×6 dose matrix using the same conditions as the cell growth assay. By using the highest single compound model [18] we found that TMP (from Chuan-xiong with Warm properties) in combination with HYA (from Hong-hua with Warm properties) caused moderate synergistic pro-angiogenic activity, whereas antagonistic effects were observed when TMP was combined with AST (from Huang-qi with Warm properties). Noticeably, TMP and TSA (from Zhi-mu with Cool properties) produced obvious antagonism at higher concentrations (Figure 3). We also observed that the traditional herb pairs Chuan-xiong and Huang-qi, and the novel herb pairs Chuan-xiong and Hong-hua identified by DMIM exhibited clear combination effects on endothelial cell proliferation. These results suggest that the different interaction patterns of herb pairs may be associated with their different herb properties, although this association remains unclear.
Figure 3

Combination effects in DMIM-extracted herb pairs.According to the HSC model, the dose matrix indicates the combined response of TMP in combination with three other compounds at six different doses. The color of the gird denotes the level of cell growth stimulation or inhibition. The growth percentage and inhibition percentage were calculated by the pro- or anti-angiogenic screening model respectively (A, C and E). B, D and F show the calculated excess growth or inhibition percentage over the HSC additivity model. The percentage above or below zero denotes the combination with synergism or antagonism, respectively.

Combination effects in DMIM-extracted herb pairs.According to the HSC model, the dose matrix indicates the combined response of TMP in combination with three other compounds at six different doses. The color of the gird denotes the level of cell growth stimulation or inhibition. The growth percentage and inhibition percentage were calculated by the pro- or anti-angiogenic screening model respectively (A, C and E). B, D and F show the calculated excess growth or inhibition percentage over the HSC additivity model. The percentage above or below zero denotes the combination with synergism or antagonism, respectively.

Co-module underlying DMIM-extracted herbal formula in treating different diseases

DMIM can recover and connect all six herbs of the Liu-wei-di-huang formula. This formula is reported to potentially treat 16 types of diseases (Additional file 1). Thus, we performed a co-module analysis to explore the potential combination mechanism of DMIM-extracted herbal formula. Table 4 shows that LWDH genes as well as LWDH-disease genes are mainly enriched in cancer pathways and neuro-endocrine-immune pathways (see Additional file 2 for detailed statistics). Moreover, based on the PPI network, it is noted that the average shortest path length is significantly smaller between LWDH genes and LWDH-disease genes than between LWDH genes and randomly selected disease genes (P<0.0001, 2000 permutations). This highlights the specificity of the LWDH for treating these 16 different diseases. In addition to this, the average phenotype similarity scores for these 16 LWDH diseases are higher than the scores of random controls (P=0.0248, 2000 permutations), suggesting that it might be possible to group together LWDH-treated diseases through a common molecular basis. These findings evidenced that LWDH might act on a common network target underlying these diseases, and we can capture the “one formula, different diseases” relationship from a co-module viewpoint based on multilayer networks of herb-biomolecule-disease (Figure 4).
Table 4

Enriched pathways of Liu-wei-di-huang genes and Liu-wei-di-huang-treated disease genes identified by DAVID

CategoryEnriched KEGG pathwayFalse discovery rate
Liu-wei-di-huang geneshsa05200:Pathways in cancer1.82E-06
hsa05014:Amyotrophic lateral sclerosis3.82E-06
hsa04620:Toll-like receptor signaling pathway6.42E-06
hsa04660:T cell receptor signaling pathway1.56E-05
hsa04210:Apoptosis8.13E-04
hsa04621:NOD-like receptor signaling pathway0.002737
hsa05222:Small cell lung cancer0.00471
hsa04080:Neuroactive ligand-receptor interaction0.007635
hsa05210:Colorectal cancer0.03486
Liu-wei-di-huang-treatedhsa05200:Pathways in cancer2.35E-12
disease geneshsa05210:Colorectal cancer1.11E-07
hsa05221:Acute myeloid leukemia2.58E-07
hsa05213:Endometrial cancer5.92E-07
hsa05220:Chronic myeloid leukemia9.79E-05
hsa05215:Prostate cancer1.38E-04
hsa04930:Type II diabetes mellitus2.25E-04
hsa05218:Melanoma3.68E-04
hsa05216:Thyroid cancer0.002937
hsa05214:Glioma0.005064
hsa05223:Non-small cell lung cancer0.008102
hsa04950:Maturity onset diabetes of the young0.01155
hsa05212:Pancreatic cancer0.019292
Figure 4

The co-module underlying For the herb module, two herbs from the Liu-wei-di-huang are linked if they have common responsive genes. For the disease module, two diseases are linked if they have common disease genes. The width of the solid lines is scaled with the number of common herb or disease genes. All herb genes and disease genes are mapped to the protein-protein interaction network. A biomolecular module as a common network target and associated with both the herb module and the disease module is extracted with dashed lines.

Enriched pathways of Liu-wei-di-huang genes and Liu-wei-di-huang-treated disease genes identified by DAVID The co-module underlying For the herb module, two herbs from the Liu-wei-di-huang are linked if they have common responsive genes. For the disease module, two diseases are linked if they have common disease genes. The width of the solid lines is scaled with the number of common herb or disease genes. All herb genes and disease genes are mapped to the protein-protein interaction network. A biomolecular module as a common network target and associated with both the herb module and the disease module is extracted with dashed lines.

Discussion

In this work, we proposed a distance-based mutual information model, DMIM, to uncover the combination rule embedded in herbal formulae, which not only uses mutual information entropy but also introduces a new factor, “between-herb-distance”, into measuring the tendency of two herbs to form an herb pair. This makes DMIM suitable for deciphering herbal formulae and distinguishes it from other analytical methods such as clustering. For example, herb1 and herb2 are often used together to reduce toxicity and side-effects, while herb2 and herb3 may be clustered into a single category because of their co-location in similar organs or meridians. According to the principles of clustering, herb1, herb2 and herb3 may be clustered into one category, but in reality, herb1 and herb3 have no inherent relationship. Moreover, the results of clustering are qualitative rather than quantitative and clustering does not show which herbs have a tendency to form herb pairs. DMIM avoids these pitfalls by calculating the mutual information entropy for each of the herbs and their “between-herb-distance”. We demonstrated the reliability and usefulness of DMIM by using 3865 Collaterals-related herbal formulae. Firstly, we showed that the DMIM method retains the traditional combination rule of TCM. DMIM identified many herbal pairs which have already been defined (Table 3). We also found that the DMIM-extracted herb network identified six classical herbal formulae from the paired herbs (Figure 1), which are expressed as connected sub-networks. On the other hand, DMIM-extracted herb network can eliminate the disturbance from herbs such as Gan-cao (Radix Rhizoma Glycyrrhizae), a widely used “Guide” herb that coordinates the actions of other herbs in formulae, though it ranks at top 2 in 3865 herbal formulae. Next, we showed that DMIM has the potential to discover angiogenic herbs and non-addictive herb pairs from TCM. This study found that the 10 most common herbs in the 3865 formulae had potential angiogenic effects (Table 2) [9,22]. We also conducted in vitro assay to evaluate the extended hub module for Chuan-xiong (Rhizoma Chuanxiong) and Dang-gui (Radix Angelicae Sinensis) in the DMIM-extracted herb network (Figure 2A). As the ingredients of herbs are very complicated and the quality of herbs is still unstable, for simplify, this work used major ingredients of herbs to perform experiments. Results showed that the herbs or herb pairs in the hub modules produced anti-angiogenic or pro-angiogenic activities, suggesting that the modular herbs may have functional dependence. In particular, we detected the novel bioactivity of two herb ingredients which inhibited angiogenesis, including Vitexicarpin (IC50 = 3.2 μM) and Timosaponin A-III (IC50 = 3.4 μM) (Figure 2B). We also validated the synergistic effects produced by DMIM-extracted novel herb pairs such as Chuan-xiong and Hong-hua (Table 3 and Figure 3). Additionally, in this study, we observed that the active compounds from the herbs with different natural properties might account for their different angiogenic responses (Figure 2B). For instance, major ingredients from Cool/Cold herbs tend to produce anti-angiogenic activities whereas major ingredients from Warm/Hot herbs tend to exert pro-angiogenic activities [22]. The dose-response relationship is another way to understand the characteristics of the herb’s natural properties. We found that Berberine and Tetramethylpyrazine can cause a pro-angiogenic effect at low dose and anti-angiogenic effects at high dose (Figure 2B), suggesting that some herbs may cause biphasic regulation if different dosing regimens are used. For herb interaction effects we assumed that herb pairs in a formula with the same properties were more likely to lead to synergistic interactions, whereas combinations with different properties were inclined to cause antagonism. As shown in Figure 3, combination effects from herb pairs with the same properties (e.g. Chuan-xiong and Hong-hua) and different properties (e.g. Chuan-xiong and Zhi-mu) support our assumption, but the combination of Chuan-xiong and Huang-qi is not the case, making it an open question whether or not herbal properties are related to herb combination behaviours. Last but not least, we demonstrated that the DMIM-extracted herbal formula, Liu-wei-di-huang, may have its molecular basis for treating different diseases in a co-module manner (Figure 4). LWDH is one of the most famous TCM formulae developed during the Song dynasty in China. Results show that the six herbs in LWDH not only have high DMIM scores, but also connected closely with common responsive genes enriched in cancer pathways and neuro-endocrine-immune pathways (Table 4). Interestingly, LWDH genes show a significantly close relationship with LWDH-disease genes in the PPI network (P<0.0001), forming a co-module underlying herbal formula as well as different diseases. Moreover, the 16 LWDH-treated diseases mainly including cancer, neuro-endocrine-immune-metabolism, and cardiovascular disorders show high phenotype similarity scores (P=0.0248) and might share a overlapped molecular basis associated with the angiogenic processes as well as the imbalance of the human body [23,24]. Such phenomena of “one formula, different diseases” reinforce the idea that different diseases with similar phenotypes might possess internal coherence [25-27], and a group of diseases with similar mechanisms might be able to be treated by intervening their common network target [28,29], which in turn illustrates the rationality of multicomponent therapies such as herbal formulae (Figure 4). The novel concept of co-module throughout the multilayer networks of herb-biomolecule-diseases may promote our awareness of herbal formulae as well as multicomponent therapies. DMIM is currently the first step towards building herb network from TCM herbal formula. For future work, DMIM could be generalized to mine synergistic combinations made up of more than two herbs by replacing the “between-herb-distance” with a properly defined index of the distance among multiple herbs in a formula or by introducing multivariate mutual information. As this work treats formula independently, we will take the redundancies and correlations between formulae into consideration for calculating the herb distance. The dose information and natural properties of herbs (as measures of interaction) are also the next step to create a multi-weight herb network. Moreover, we believe that the combination mechanism of herbal formulae will be more deeply identified in a “co-module” manner and contribute to the progression of the modern TCM as well as network pharmacological studies [13].

Conclusions

DMIM yields a systematic framework for scoring herb pairs and the resulted herb network can uncover some combination rules of TCM. We also provide preliminary clues that the “co-module” across multilayer networks of herb-biomolecule-disease may be responsible for the combination mechanism underlying herbal formulae. This study is the first step forward in exploring the unique theories of TCM herbal formula by network biology approaches and may also benefit the coming network pharmacology as well.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SL conceived and designed the experiments, analyzed the data and wrote manuscript. BZ participated in the cell experiments and writing manuscript. YW, DJ and NZ participated in the computational works and writing manuscript.
  24 in total

Review 1.  Synergy and other interactions in phytomedicines.

Authors:  E M Williamson
Journal:  Phytomedicine       Date:  2001-09       Impact factor: 5.340

2.  Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts.

Authors:  Shanshan Wang; Zhengui Zheng; Yinqi Weng; Yijun Yu; Daifu Zhang; Weihu Fan; Ruihong Dai; Zhibi Hu
Journal:  Life Sci       Date:  2004-04-02       Impact factor: 5.037

3.  Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network.

Authors:  Tao Ma; Conge Tan; Hui Zhang; Miqu Wang; Weijun Ding; Shao Li
Journal:  Mol Biosyst       Date:  2010-01-07

Review 4.  Multicomponent therapeutics for networked systems.

Authors:  Curtis T Keith; Alexis A Borisy; Brent R Stockwell
Journal:  Nat Rev Drug Discov       Date:  2005-01       Impact factor: 84.694

Review 5.  A robustness-based approach to systems-oriented drug design.

Authors:  Hiroaki Kitano
Journal:  Nat Rev Drug Discov       Date:  2007-02-23       Impact factor: 84.694

Review 6.  Revisiting the ancient concept of botanical therapeutics.

Authors:  Barbara M Schmidt; David M Ribnicky; Peter E Lipsky; Ilya Raskin
Journal:  Nat Chem Biol       Date:  2007-07       Impact factor: 15.040

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Suppressive effects of a Chinese herbal medicine qing-luo-yin extract on the angiogenesis of collagen-induced arthritis in rats.

Authors:  Shao Li; Ai-Ping Lu; Yong-Yan Wang; Yan-Da Li
Journal:  Am J Chin Med       Date:  2003       Impact factor: 4.667

Review 9.  Botanical immunodrugs: scope and opportunities.

Authors:  Bhushan Patwardhan; Manish Gautam
Journal:  Drug Discov Today       Date:  2005-04-01       Impact factor: 7.851

10.  Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines.

Authors:  Lynn S Adams; Navindra P Seeram; Mary L Hardy; Catherine Carpenter; David Heber
Journal:  Evid Based Complement Alternat Med       Date:  2006-03       Impact factor: 2.629

View more
  99 in total

Review 1.  Bioinformatics opportunities for identification and study of medicinal plants.

Authors:  Vivekanand Sharma; Indra Neil Sarkar
Journal:  Brief Bioinform       Date:  2012-05-15       Impact factor: 11.622

2.  Study on the networks of "Nature-Family-Component" of Chinese medicinal herbs based on association rules mining.

Authors:  Xian-jun Fu; Zhen-guo Wang; Yi Qu; Peng Wang; Yang Zhou; Hua-yun Yu
Journal:  Chin J Integr Med       Date:  2013-08-24       Impact factor: 1.978

3.  Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.

Authors:  Yan-qiong Zhang; Song-song Wang; Wei-liang Zhu; Yan Ma; Fang-bo Zhang; Ri-xin Liang; Hai-Yu Xu; Hong-jun Yang
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

4.  Text Mining of Rheumatoid Arthritis and Diabetes Mellitus to Understand the Mechanisms of Chinese Medicine in Different Diseases with Same Treatment.

Authors:  Ning Zhao; Guang Zheng; Jian Li; Hong-Yan Zhao; Cheng Lu; Miao Jiang; Chi Zhang; Hong-Tao Guo; Ai-Ping Lu
Journal:  Chin J Integr Med       Date:  2018-01-09       Impact factor: 1.978

5.  Hot and Cold Theory: Evidence in Systems Biology.

Authors:  Farideh Bahari; Maryam Yavari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach.

Authors:  Quan Qi; Rui Li; Hui-Ying Li; Yu-Bing Cao; Ming Bai; Xiao-Jing Fan; Shu-Yan Wang; Bo Zhang; Shao Li
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

7.  Exploring traditional chinese medicine by a novel therapeutic concept of network target.

Authors:  Shao Li
Journal:  Chin J Integr Med       Date:  2016-05-04       Impact factor: 1.978

8.  An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin.

Authors:  Bo Zhang; Xu Wang; Shao Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-09       Impact factor: 2.629

9.  A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment.

Authors:  Xiuxiu Li; Xue Xu; Jinan Wang; Hua Yu; Xia Wang; Hongjun Yang; Haiyu Xu; Shihuan Tang; Yan Li; Ling Yang; Luqi Huang; Yonghua Wang; Shengli Yang
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

10.  Histone modifications and traditional Chinese medicinals.

Authors:  Hsin-Ying Hsieh; Pei-Hsun Chiu; Sun-Chong Wang
Journal:  BMC Complement Altern Med       Date:  2013-05-27       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.